drugset / Trial / NCT07671391
A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body in Obese Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized, double-blind, placebo-controlled trial aimed at exploring the effects of LAE102 injection in combination with Tirzepatide on body composition.
Timeline
- Start
- 2026-08
- Primary completion
- 2027-07
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAE102 | Unknown | — | Subcutaneous |
| Background | Tirzepatide | Peptide | — | Subcutaneous |
Indications
No indication recorded.